Novartis, the planet's top healthcare business, was fashioned in 1996 out of a merger of two quite different, mid-grade Switzerland-based pharma companies. The case traces the business evolution over the past 17 years, as it transformed into a truly global enterprise with 127,000 employees of 153 nationalities in 140 countries creating $56.7 billion in 2012 revenues and $9.6 billion in net income, making the business one of the world's largest and most lucrative companies.
Novartis Leading a Global Enterprise Case Study Solution
CEO since 2010, Joe Jimenez had taken over from airy legacy CEO Daniel Vasella and one of the architects of the amalgamation. He understood that Novartis needed to make sure it had the correct strategy, structure, talent and spirit to live up to its dreams and the global health care environment would create intense challenges for Novartis in the years ahead.
PUBLICATION DATE: May 27, 2013 PRODUCT #: 413096-HCB-ENG
This is just an excerpt. This case is about STRATEGY & EXECUTION
Related Case Solutions & Analyses:
Project Dial-Tone
McDonalds: The Arch Deluxe Launch
Transforming Tommy Hilfiger (B)
LVMH Moët Hennessy – Louis Vuitton: A Personal Career Destination
Value Creation and Capture
Porsche: The Cayenne Launch
The Cheezburger Network
Can Brand Image Move Upwards After Sideways? A Strategic Approach to Brand Placements
Weight Watchers Mexico
Aravind Eye Care’s Vision Centers – Reaching Out to the Rural Poor
